132 related articles for article (PubMed ID: 38133816)
21. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
22. p38 MAP kinase mediates the cell death induced by PrP106-126 in the SH-SY5Y neuroblastoma cells.
Thellung S; Villa V; Corsaro A; Arena S; Millo E; Damonte G; Benatti U; Tagliavini F; Florio T; Schettini G
Neurobiol Dis; 2002 Feb; 9(1):69-81. PubMed ID: 11848686
[TBL] [Abstract][Full Text] [Related]
23. Oxidation reduces the fibrillation but not the neurotoxicity of the prion peptide PrP106-126.
Bergström AL; Chabry J; Bastholm L; Heegaard PM
Biochim Biophys Acta; 2007 Sep; 1774(9):1118-27. PubMed ID: 17707142
[TBL] [Abstract][Full Text] [Related]
24. PrP106-126 amide causes the semi-penetrated poration in the supported lipid bilayers.
Zhong J; Zheng W; Huang L; Hong Y; Wang L; Qiu Y; Sha Y
Biochim Biophys Acta; 2007 Jun; 1768(6):1420-9. PubMed ID: 17451641
[TBL] [Abstract][Full Text] [Related]
25. Parkin Overexpression Ameliorates PrP106-126-Induced Neurotoxicity via Enhanced Autophagy in N2a Cells.
Khan SH; Zhao D; Shah SZ; Hassan MF; Zhu T; Song Z; Zhou X; Yang L
Cell Mol Neurobiol; 2017 May; 37(4):717-728. PubMed ID: 27430567
[TBL] [Abstract][Full Text] [Related]
26. The role of prion peptide structure and aggregation in toxicity and membrane binding.
Rymer DL; Good TA
J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
[TBL] [Abstract][Full Text] [Related]
27. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
Brown DR
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
[TBL] [Abstract][Full Text] [Related]
28. Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106-126.
Kanapathipillai M; Ku SH; Girigoswami K; Park CB
Biochem Biophys Res Commun; 2008 Jan; 365(4):808-13. PubMed ID: 18039468
[TBL] [Abstract][Full Text] [Related]
29. Lithium alleviates neurotoxic prion peptide-induced synaptic damage and neuronal death partially by the upregulation of nuclear target REST and the restoration of Wnt signaling.
Song Z; Yang W; Zhou X; Yang L; Zhao D
Neuropharmacology; 2017 Sep; 123():332-348. PubMed ID: 28545972
[TBL] [Abstract][Full Text] [Related]
30. Structural diversity and initial oligomerization of PrP106-126 studied by replica-exchange and conventional molecular dynamics simulations.
Ning L; Guo J; Bai Q; Jin N; Liu H; Yao X
PLoS One; 2014; 9(2):e87266. PubMed ID: 24586266
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX
Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330
[TBL] [Abstract][Full Text] [Related]
32. Review: PrP 106-126 - 25 years after.
Forloni G; Chiesa R; Bugiani O; Salmona M; Tagliavini F
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):430-440. PubMed ID: 30635947
[TBL] [Abstract][Full Text] [Related]
33. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.
Sassoon J; Daniels M; Brown DR
Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751
[TBL] [Abstract][Full Text] [Related]
34. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
Kawahara M; Koyama H; Nagata T; Sadakane Y
Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
[TBL] [Abstract][Full Text] [Related]
35. PrP106-126 peptide disrupts lipid membranes: influence of C-terminal amidation.
Zheng W; Wang L; Hong Y; Sha Y
Biochem Biophys Res Commun; 2009 Feb; 379(2):298-303. PubMed ID: 19103159
[TBL] [Abstract][Full Text] [Related]
36. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
[TBL] [Abstract][Full Text] [Related]
37. Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.
Ning L; Pan D; Zhang Y; Wang S; Liu H; Yao X
PLoS One; 2015; 10(5):e0125899. PubMed ID: 25993001
[TBL] [Abstract][Full Text] [Related]
38. Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases.
Yuan F; Yang L; Zhang Z; Wu W; Zhou X; Yin X; Zhao D
J Mol Neurosci; 2013 Sep; 51(1):219-24. PubMed ID: 23715697
[TBL] [Abstract][Full Text] [Related]
39. Interaction between 14-3-3β and PrP influences the dimerization of 14-3-3 and fibrillization of PrP106-126.
Han J; Song QQ; Sun P; Zhang J; Wang X; Song J; Li GQ; Liu YH; Mei GY; Shi Q; Tian C; Chen C; Gao C; Zhao B; Dong XP
Int J Biochem Cell Biol; 2014 Feb; 47():20-8. PubMed ID: 24269782
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
Kourie JI
Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
